Piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exercise
1996

Piroxicam and Delayed Muscle Soreness

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): J-L. Croisier, G. Caius, CA T. Monfils, G. Deby-Dupon, M. Fafchamps, I. Venneman, J-M. Crielaard, A. Juchms-Ferir, C. Lhermerout, M. Lamy, C. Deby

Primary Institution: University of Liege

Hypothesis

Delayed onset muscular soreness (DOMS) following intense eccentric muscle contraction could be due to increased production of prostaglandin E2 (PGE2).

Conclusion

Oral administration of piroxicam fails to reduce muscle damage and DOMS caused by strenuous eccentric exercise.

Supporting Evidence

  • The mean plasma concentration of PGE2 was significantly lower in the group treated with piroxicam.
  • Maximal soreness was noted 48 hours post-exercise.
  • Serum creatine kinase activity and myoglobin concentration increased significantly after exercise.

Takeaway

This study looked at whether a medicine called piroxicam could help with muscle soreness after exercise, but it didn't work.

Methodology

Ten healthy male subjects performed isokinetic tests with either placebo or piroxicam, and muscle soreness and damage were measured.

Limitations

The study only included healthy male subjects, which may limit the generalizability of the results.

Participant Demographics

Ten moderately active, healthy male subjects with a mean age of 22 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication